chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Started feeling sickly around November 20, 2021.  Hospitalized in March 2022 to drain built-up fluid due to Pericarditis and ran many tests , including but not limited to cancer test, to determine the cause  of pericardial effusion.  Unable to determine the cause conclusively.  The condition of pericardial effusion slowly came back and the hospital performed pericardiectomy in June, 2022.
Arm red & swollen & hot, fever 105 to 106; sz in & out 10-15 min;
Arm red at site of injection.  Large area on upper arm.  Hot to touch, painful - patient woke from sleep with pain.
Associate complained of a red area at the injection site with a small lump under the skin. Advised to apply heat compress on and off throughout the evening when she is off work.
patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On an unknown date, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  The reporter stated that, their facility had not been able to download the digital data logger, they had been put on hold by the state at the moment.   It was reported that there had been no power outages that would have impacted the Moderna vaccine. However, the Healthcare professional reiterates that because  facility was unable to download the digital data logger, they would need to treat this issue as a temperature excursion. The data logger was unable to download for the months of Dec-2021, Jan-2022, and Feb-2022. They were filling out a temperature excursion assessment with the State at that time. It was reported that no adverse reactions were reported by any patients.  No treatment medications were reported   This case was linked to MOD-2022-501575 (Patient Link).
With Pfizer, same day numbness in skin (hypoaesthesia). Right side arm at first. Numbness would come and go in arms and legs and face. This went on until November of 2021. Went away fully. After 2nd dose, had tingling in legs for about a week.  After taking Moderna at advice of PCP due to previous symptoms, 5 days after that booster dose, started getting twitching in nose anout 2 weeks, then it migrated to left eye. I have had 1 round of Prednisone and it improved but never fully went away.  2 days after that final dose, it started back but not as severe. Now left eye  feels like it wants to drop.  Recently started hormone replacement therapy last summer- 2 doses of pellet therapy- last dose was November 3rd. This month started Estradiol patch and started Progesterone when started therapy last year. Started and stopped D3 and B12 this past year.  All other meds listed prior are the same.
Hight temperature 101.5/ Headach / Body aches / Weakness / dizziness / Symptoms similar to flu but without congestion / Patient took Aleve, Tylenol & Advil but it didn't help with the symptoms ... Patient will go to the clinic today to be check up.
1 of 4 pts vaxed from the same vial who had an adverse event;pt exp erythema & swelling from the shoulder to elbow of vaxed arm;seen by MD dx cellulitis (no cultures done); rx w/ATB
I have had 4 Moderna's previous with very intense reactions; This spontaneous case was reported by a consumer and describes the occurrence of IMMUNISATION REACTION (I have had 4 Moderna's previous with very intense reactions) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.   In 2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced IMMUNISATION REACTION (I have had 4 Moderna's previous with very intense reactions). At the time of the report, IMMUNISATION REACTION (I have had 4 Moderna's previous with very intense reactions) outcome was unknown.            No concomitant medications were reported. No treatment medications were reported.   This case was linked to US-MODERNATX, INC.-MOD-2022-645552 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-645552:Husband's case
Client felt light/headed dizzy immediately after vaccination.  Stated he felt like he was going to ?pass out?. Appeared pale and pulse weak.  Assisted to ground with elevation of legs. No LOC or injury. Symptoms resolved. Pulse palpated and no longer weak.  He states he has had this happen in the past after a blood draw. Initial vitals 129/68, hr 66. Bottled water given to client. Client remained at site and monitored for 45 minutes after incident. Vitals remained stable. Declined further evaluation.  Vitals prior to leaving bp 129/75, hr 72.
Patient who is late on 3rd dose of RabAvert vaccine for post-exposure prophylaxis; Case reference number US-BN-2020-019904 is a spontaneous case report initially received from a nurse via Agency(reference number USBAV20-0247) on 28-Dec-2020, and concerns a 21-year-old male patient.  The patient's medical history and concomitant medication details were not provided.  On 03-Dec-2020, the patient received RabaVert (Inactivated Rabies Virus Vaccine, Batch no. was not provided) at unknown dose for post-exposure prophylaxis.  On 11-Dec-2020, the patient received second dose of RabaVert (Batch no. was not provided) at unknown dose for post-exposure prophylaxis.  The patient was late on third dose of RabaVert vaccine for post-exposure prophylaxis (inappropriate schedule of vaccine administered).   *At the time of this report it was known that the patient had no known adverse reactions due to RabaVert.*  All follow-up information is blended into the case narrative above, with the latest information presented between asterisks (*).   Follow up information was received from a nurse on 27-Jan-2021: Information included updated patient's details and confirmation that the patient had no known adverse events due to RabaVert.; Reporter's Comments: Inappropriate schedule of vaccine administered is listed by convention. Reportedly, the patient was late on the third dose of RabAvert vaccine for post-exposure prophylaxis which is considered to be inappropriate schedule of vaccine administered. No adverse events were reported. Inappropriate schedule of vaccine administered is not related to the vaccine itself, but to human action.; Sender's Comments: Inappropriate schedule of vaccine administered is listed by convention. Reportedly, the patient was late on the third dose of RabAvert vaccine for post-exposure prophylaxis which is considered to be inappropriate schedule of vaccine administered. No adverse events were reported. Inappropriate schedule of vaccine administered is not related to the vaccine itself, but to human action.
Nausea, vomiting, dizziness,head ache, diarrhea also arm injection was put it is very painful and swollen
Patient c/o redness, swelling at injection site of left deltoid on evening of injection (03-17-15) the swelling and redness continued for 3 days, extended to mid upper arm. The arm was hot, skin peeled. Ice was applied per patient.
Rapid Heart Rate - between 120-150bpm for more than 6hrs; diarrhea; This is spontaneous report received from a contactable consumer (patient herself). A 29-year-old female non-pregnant patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection, Lot number: EL3248) via an unspecified route of administration on left arm on 14Jan2021 06:45 at Single Dose and then second dose via an unspecified route of administration (lot number: EL3248) on left arm on 03Feb2021 06:45 at Single Dose for COVID-19 immunisation. Medical history included hypothyroidism and COVID.  Concomitant medication included levothyroxine and unspecified Birth control (received within two weeks of vaccination). The patient previously took cefaclor (CECLOR), amoxicillin sodium/ clavulanate potassium (AUGMENTIN) and experienced known allergies with both. It was reported that, the patient experienced rapid heart rate between 120-150bpm for more than 6hrs in 2021. Went to the ER (Emergency Room). Beta blocker was given to lower heart rate. This started about 6hrs after vaccine was administered. Also had diarrhea for 3 days after vaccination. The patient had COVID-19 prior to the vaccination. The patient not tested for COVID post vaccination. The outcome of the event diarrhea was recovered in 2021 whereas recovering for another event.
lymph nodes in her armpit; on the same side as her injection, is sore.; This is a spontaneous report from a contactable consumer (patient).  A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number was not reported) via an unspecified route of administration on 28Jan2021 as, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On 28Jan2021 the patient experienced lymph nodes in her armpit, on the same side as her injection, is sore. She believes that she noticed the soreness a couple of days but the soreness was really apparent yesterday and today .The outcome of the events was unknown.  Follow-up attempts are completed. No further information is expected.
This spontaneous report as received from a pharmacist refers to a patient of unknown age. The reporter reported that the patient received an expired PNEUMOVAX 23 (lot # 669579/0595AA, expired date 30-AUG-2012) on 10-SEP-2012. No adverse effect reported. Additional information has been requested.
Rhinitis, watery and itchy eyes, sore throat, fatigue, cough.
NauseaVomiting pain Narrative: employee states: late the night of the injection she experienced left arm pain, left shoulder pain, left sided collar bone pain, neck pain and chest pain. She had some tingling in her left hand but the only lasted 1-2 hours. she had an upset stomach on 1/27/21 as well as severe nausea and vomiting.
Left drs office, baby screaming. Got home, baby screamed until she fell asleep. Put baby in bassinet and clipped Souza on her. About an hour later heard the alarm and baby wasn't breathing. Was able to get her breathing, when she got stiff. Looked it up and was a seizure. Baby continued to seize in hospital and nurse confirmed it was seizures. Baby had no fever. Projectile vomiting, dehydrated from that. I refused to leave baby there in fear of her being vaccinated again while out of my site.
5 days after receiving my recent booster, I started my menstrual cycle for September. My cramps were so painful that I quickly became nauseous and vomited. I also had diarrhea. Shortly after this episode, the cramps subsided enough that I could rest, but I was truly concerned I would have to call 9-1-1 as I live alone and felt like I would pass out. I had to call out of work from the pain. The rest of the day I had a horrible headache. My period has not been flowing regularly and I?ve had a lot of coagulation occurring.
pt recvd vax & 24 hrs p/3rd dose of vax pt exp rash on arm, pain in arm & joint pain; pt took Pred & was seen by regular MD; evaluated for poss lupus;
The patient has had body pain (like during flu) since the day after vaccination (10/09/2013) till to date (10/28/2013).
9 days post vax pt seen in ER w/t104.3, rt OM, on the way home tensed up, stopped breathing, eyes rolled back & was unresponsive to voice x several seconds;
Red injection site (The Size of a Small Apple); Itchy Injection Site; Hot to the touch Injection Site; This spontaneous case was reported by a consumer and describes the occurrence of Red injection site (The Size of a Small Apple), VACCINATION SITE PRURITUS (Itchy Injection Site) and VACCINATION SITE WARMTH (Hot to the touch Injection Site) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Apr-2021, the patient experienced Red injection site (The Size of a Small Apple), VACCINATION SITE PRURITUS (Itchy Injection Site) and VACCINATION SITE WARMTH (Hot to the touch Injection Site). At the time of the report, Red injection site (The Size of a Small Apple), VACCINATION SITE PRURITUS (Itchy Injection Site) and VACCINATION SITE WARMTH (Hot to the touch Injection Site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product usage were not provided. Treatment details were also not provided.
Diarrhea; Fullness of Stomache; Stomachache; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea), ABDOMINAL PAIN UPPER (Stomachache) and ABDOMINAL DISTENSION (Fullness of Stomache) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Mar-2021, the patient experienced ABDOMINAL PAIN UPPER (Stomachache). On 17-Mar-2021, the patient experienced ABDOMINAL DISTENSION (Fullness of Stomache). On 18-Mar-2021, the patient experienced DIARRHOEA (Diarrhea). At the time of the report, DIARRHOEA (Diarrhea) had not resolved and ABDOMINAL PAIN UPPER (Stomachache) and ABDOMINAL DISTENSION (Fullness of Stomache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant information was reported.  No treatment information was reported.
Patient received 0.2mL of the COVID-19 Pfizer dose instead of 0.3mL.
NEW ONSET SHORTNESS  OF BREATH AND CHEST DISCOMFORT CONSISTENT WITH POST-VACCINE MYOCARDITIS. 11/12/21 - ONSET; 11/26 URGENT CARE VISIT - EKG AND CBC NORMAL; 11/30 PCP VISIT - PRESUMED MYOCARDITIS DIAGNOSIS AND CARDIOLOGY FOLLOWUP ORDERED; 11/30 CTA CHEST R/O PE, EXAM UNREMARKABLE FOR DEFECTS; INITIATED INDOMETHACIN. 12/14 ECHOCARDIOGRAM, NORMAL; 11/20 CARDIOLOGY FOLLOW UP, LEXI SCAN ORDERED FOR JANUARY. 1/3/2022 CONFIRMATION FROM PCP OF DIAGNOSIS POST-VACCINE MYOCARDITIS.
pt recv vax 7NOV96 approx 3PM by 6PM devel high pitch squeal cry, lasting for 5h w/o stopping;call to MD tx-APAP if not better take to ER;by 10PM pt calmed down;
headache; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program (159558). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 20Jul2021 22:40 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (First dose), for Covid-19 immunization. The following information was reported: HEADACHE (non-serious), outcome "unknown", described as "headache". No follow-up attempts are possible. No further information is expected.  Additional information: The reporter mentioned that there was no medical issue or symptoms. She just wanted to know which medication can she take if she would experience symptoms. The reporter was asking if she can take Tylenol or Aspirin for headache in the event that it may happen after having the vaccine.  No follow-up attempts are possible. No further information is expected.
pt recv vax in 1996 & 16DEC96 pt presented w/gen chickenpox rash w/5 to 20 lesions;
sister has had the shingles shot and she still got shingles twice/suspected vaccination failure; Got shingles twice; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional case details were reported as follows: The patient was the reporter's sister. The age at vaccination was not reported. The patient had the shingles shot and still got shingles twice. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation were unknown at the time of reporting. No contact details were available.
Received vaccines 7-11-02 approx. 10:20 a.m.--developed hives Saturday 7-13-02 early a.m. (exact time unknown)--no other signs/symptoms.  Did not take anything for hives.  Called 7-15-02 to report to health dept.--hives no better or worse.  Has thme on legs, buttocks and up to waist.  Wife has same  , she also received vaccines.
Patient:  Deceased BRIEF OVERVIEW: Admission Date: 8/21/2021 Discharge Date: 8/22/2021 Active Hospital Problems   Diagnosis Date Noted POA ? Pneumonia due to COVID-19 virus 08/21/2021 Unknown ? Bacterial pneumonia 08/21/2021 Unknown ? Acute respiratory failure with hypoxia and hypercapnia 10/21/2018 Unknown DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute respiratory failure with hypoxia and hypercapnia Pneumonia of both lungs due to infectious organism, unspecified part of lung Acute hypoxemic respiratory failure due to COVID-19   HOSPITAL COURSE: 87-year-old female with history of heart failure, atrial fibrillation, SIADH, coronary artery disease, metastatic adenocarcinoma (recently diagnosed), and previous lung cancer who presented to the emergency department with hypoxia and cough noted at bed.  The patient was recently admitted to our service for a hip fracture for which she underwent repair 8-10.  She was reportedly doing well at her rehab facility when she developed hypoxia and a cough.  Chest x-ray showed changes consistent with pneumonia.  EMS was called when the patient was found to be short of breath requiring 2.5 L of oxygen.  Her oxygen saturation was in the 70s on their arrival.  She was brought to the emergency department and BiPAP was initiated.  She was febrile tachycardic.  ProBNP was elevated.  Procalcitonin was greater than 100.  COVID-19 PCR was positive.  CTA was negative for PE, but showed consolidative airspace disease and patchy ground-glass opacities.  The patient was started on IV antibiotics and admitted to the hospitalist service.  She refused steroid therapy.  IV diuresis was initiated.   On the morning following admission she refused to be placed back on BiPAP.  Goals of care were addressed with the patient at bedside and she elected for comfort care.  She had been planning to sign on to hospice services as an outpatient with her recent diagnosis of metastatic adenocarcinoma and requested their services while inpatient. Hospice was consulted and she was transitioned to inpatient hospice.  The patient's family was aware of her wishes and were supportive.  A morphine drip was initiated per hospice recommendations.  The patient passed away at 16 30 on 08/22/2021.  The medical examiner was contacted as her death occurred within 24 hours of admission, but declined the case.
This spontaneous report was received from a healthcare worker and refers to a 8 week old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 23-JUL-2015 and on 09-OCT-2015, the patient was vaccinated with two separate doses of improperly stored ROTATEQ (doses were not provided) lot # K023534, expiration date: 22-MAY-2016 and lot # K016261, expiration date: 23-JUN-2016, orally. No adverse effects were reported. Additional information has been requested.
I felt dizzy and wanted to vomit so I went quickly to the bathroom. I let myself go because I could not stand on my feet. My hands and face began to tingle and my fingers began to paralyze. I felt like my face also began to paralyze including my tongue. Now I have chills and cramps.
pt recv vax 15JUN95 & exp itching following vax;an assoc between the itching & hep B was unk;
Swelling on L leg from hip to knee. Provider recommends BENADRYL, MOTRIN and ice as needed.
Just reporting side effects of Shingrix 50mcg immunization shot - extreme exhaustion for two days, moderate headaches, moderate nausea, 101 degree fever for two days. All symptoms gone by day 4.
Vaccine at approximately 1530. Hives, dizzy, lightheaded, intermittent SOB by 1600.
Information has been received from a nurse practitioner concerning a female patient who was vaccinated from a (single dose vial) third dose of Gardasil.  Subsequently, the patient experienced injection site pain that traveled to her shoulder and back.  The physician's office advised the patient to take TYLENOL.  At the time of the report the patient's outcome was unknown.  Additional information has been requested.
complains of swollen tongue, swollen labia. Alteration of taste sensation, which did resolved.  treated with steroids on 4/24/22021.   (after receiving 2nd Moderna dose 4/20/2021.)  On 7/2/2021 complained of persistent symptoms of swelling of the tongue and genital labia.  I examined the patient's tongue, and was not able to ascertain obvious swelling.  I did not examine her genital labia.  ER doc's notes on 4/24 noted prominent papillae on lateral aspects of tongue, not other physical findings were notable, labia were normal. Cervical swab was done and positive for herpes simplex. .